摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5Z)-3-[4-Oxo-4-(10H-phenothiazin-10-YL)butyl]-2-sulfanylidene-5-[(thiophen-2-YL)methylidene]-1,3-thiazolidin-4-one

中文名称
——
中文别名
——
英文名称
(5Z)-3-[4-Oxo-4-(10H-phenothiazin-10-YL)butyl]-2-sulfanylidene-5-[(thiophen-2-YL)methylidene]-1,3-thiazolidin-4-one
英文别名
(5Z)-3-(4-oxo-4-phenothiazin-10-ylbutyl)-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-thiazolidin-4-one
(5Z)-3-[4-Oxo-4-(10H-phenothiazin-10-YL)butyl]-2-sulfanylidene-5-[(thiophen-2-YL)methylidene]-1,3-thiazolidin-4-one化学式
CAS
——
化学式
C24H18N2O2S4
mdl
——
分子量
494.7
InChiKey
NAORDQKTRIGKPV-QNGOZBTKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    32
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    152
  • 氢给体数:
    0
  • 氢受体数:
    6

文献信息

  • Oxazole and thiazole compounds as beta-catenin modulators and uses thereof
    申请人:Dasgupta Ramanuj
    公开号:US20090227624A1
    公开(公告)日:2009-09-10
    A series of oxazole and thiazole compounds are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of β-cat oxazole and thiazole compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others.
  • OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF
    申请人:Dasgupta Ramanuj
    公开号:US20130109675A1
    公开(公告)日:2013-05-02
    A series of oxazole and thiazole compounds are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of β-cat oxazole and thiazole compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others.
  • US8252823B2
    申请人:——
    公开号:US8252823B2
    公开(公告)日:2012-08-28
  • US9433611B2
    申请人:——
    公开号:US9433611B2
    公开(公告)日:2016-09-06
查看更多